| Field | Row 1 |
|---|---|
| adsh | 0001213900-25-042011 |
| cik | 1788028 |
| name | JASPER THERAPEUTICS, INC. |
| sic | 2836 |
| countryba | US |
| stprba | CA |
| cityba | REDWOOD CITY |
| zipba | 94065 |
| bas1 | 2200 BRIDGE PKWY SUITE #102 |
| bas2 | |
| baph | 6505491400 |
| countryma | US |
| stprma | CA |
| cityma | REDWOOD CITY |
| zipma | 94065 |
| mas1 | 2200 BRIDGE PKWY SUITE #102 |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 842984849 |
| former | AMPLITUDE HEALTHCARE ACQUISITION CORP |
| changed | 20190912 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250512 |
| accepted | 2025-05-12 16:01:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | ea0239735-10q_jasper_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-042011 | 20241231 | Assets Current | 75811000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Liabilities And Stockholders Equity | 57597000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Net Cash Provided By Used In Financing Activities | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042011 | 20250331 | Operating Expenses | 21802000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Operating Income Loss | -15072000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Other Liabilities Noncurrent | 2264000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Other Noncash Expense | 193000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Preferred Stock Shares Outstanding | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-042011 | 20250331 | Proceeds From Stock Options Exercised | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042011 | 20240331 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042011 | 20250331 | Stockholders Equity | 304352000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042011 | 20240331 | Stock Issued During Period Value Issuance Of Common Stock Through Underwritten Offering | USD | 1 | 0001213900-25-042011 | Equity Components= Retained Earnings; | |||
| 0001213900-25-042011 | 20240331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042011 | 20250331 | Cash And Cash Equivalents At Carrying Value | 48799000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 72054000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 49216000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Common Stock Shares Authorized | 492000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Common Stock Value | 2000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | General And Administrative Expense | 4774000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | General And Administrative Expense | 5645000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Increase Decrease In Accounts Payable | -1039000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Increase Decrease In Operating Lease Liability | -315000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Operating Expenses | 15072000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Payments To Acquire Machinery And Equipment | 25000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Proceeds From Issuance Of Common Stock | 47195000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Research And Development Expense | 10298000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Retained Earnings Accumulated Deficit | -240869000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20231231 | Stockholders Equity | 248039000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042011 | 20240331 | Stockholders Equity | -183328000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042011 | 20241231 | Stockholders Equity | 302541000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042011 | 20240331 | Stock Issued During Period Value Issuance Of Common Stock Through Underwritten Offering | 47195000.0000 | USD | 1 | 0001213900-25-042011 | |||
| 0001213900-25-042011 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 154000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042011 | 20250331 | Liabilities | 15353000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Additional Paid In Capital | 304352000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-042011 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-042011 | 20241231 | Common Stock Shares Outstanding | 15022122.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Common Stock Value | 2000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Earnings Per Share Diluted | -1.0300 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Investment Income Interest | 624000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Issuance Of Common Stock Through Underwritten Offering Net Of Discounts And Commissions And Issuance Cost | 3900000.0000 | shares | 1 | 0001213900-25-042011 | Equity Components= Common Stock; | ||
| 0001213900-25-042011 | 20241231 | Liabilities | 18225000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Net Income Loss | -13728000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042011 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042011 | 20250331 | Operating Lease Right Of Use Asset | 1875000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Preferred Stock Shares Issued | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-042011 | 20250331 | Proceeds From Issuance Of Common Stock | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042011 | 20250331 | Proceeds From Sale Of Property Plant And Equipment | 4000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Reclassification Of Common Stock Warrant Liability To Equity | 1092000.0000 | USD | 1 | 0001213900-25-042011 | |||
| 0001213900-25-042011 | 20241231 | Restricted Cash Noncurrent | 417000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Retained Earnings Accumulated Deficit | -262110000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Share Based Compensation | 1811000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20231231 | Shares Outstanding | 11163896.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042011 | 20231231 | Stockholders Equity | 78440000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 21657.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042011 | 20240331 | Stock Issued During Period Value Issuance Of Common Stock Through Underwritten Offering | 1000.0000 | USD | 1 | 0001213900-25-042011 | Equity Components= Common Stock; | ||
| 0001213900-25-042011 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 13334900.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042011 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 87304000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Common Stock Shares Issued | 15022122.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Depreciation And Amortization | 288000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Earnings Per Share Diluted | -1.4100 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Increase Decrease In Accounts Payable | -1758000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -2617000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Increase Decrease In Operating Lease Liability | -233000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 201000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Investment Income Interest | 1386000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Liabilities And Stockholders Equity | 79899000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Net Cash Provided By Used In Investing Activities | -25000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Net Cash Provided By Used In Operating Activities | -15736000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Net Cash Provided By Used In Operating Activities | -22842000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Net Income Loss | -13728000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-042011 | 20250331 | Nonoperating Income Expense | 561000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Operating Income Loss | -21802000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Operating Lease Liability Current | 1089000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Payments To Acquire Machinery And Equipment | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042011 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-042011 | 20240331 | Reclassification Of Common Stock Warrant Liability To Equity | USD | 1 | 0001213900-25-042011 | ||||
| 0001213900-25-042011 | 20240331 | Share Based Compensation | 1169000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Shares Outstanding | 15022122.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042011 | 20241231 | Stockholders Equity | 61674000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042011 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 13334900.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 15022122.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Accounts Payable Current | 2995000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Accounts Payable And Other Accrued Liabilities Current | 10121000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 1169000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042011 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-042011 | 20250331 | Common Stock Shares Outstanding | shares | 0 | us-gaap/2025 | Class Of Stock= Non Voting Common Stock; | |||
| 0001213900-25-042011 | 20240331 | Increase Decrease In Other Noncurrent Assets | 80000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Net Cash Provided By Used In Financing Activities | 47349000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042011 | 20250331 | Net Income Loss | -21241000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042011 | 20250331 | Operating Lease Liability Noncurrent | 755000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Preferred Stock Shares Outstanding | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-042011 | 20240331 | Proceeds From Sale Of Property Plant And Equipment | USD | 1 | us-gaap/2025 | ||||
| 0001213900-25-042011 | 20250331 | Research And Development Expense | 16157000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20231231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042011 | 20240331 | Stockholders Equity | 296556000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042011 | 20250331 | Stockholders Equity | 42244000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Stockholders Equity | -262110000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042011 | 20240331 | Stock Issued During Period Value Issuance Of Common Stock Through Underwritten Offering | 47194000.0000 | USD | 1 | 0001213900-25-042011 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042011 | 20240331 | Stock Issued During Period Value Net Of Discounts And Commissions And Issuance Cost | 3300.0000 | USD | 1 | 0001213900-25-042011 | |||
| 0001213900-25-042011 | 20250331 | Accounts Payable And Other Accrued Liabilities Current | 7504000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Additional Paid In Capital | 302541000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 1811000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 1811000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001213900-25-042011 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 31588000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-042011 | 20250331 | Common Stock Shares Outstanding | 15022122.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Depreciation And Amortization | 300000.0000 | USD | 1 | us-gaap/2025 | Fair Value By Asset Class= Property Plant And Equipment; | ||
| 0001213900-25-042011 | 20250331 | Depreciation And Amortization | 279000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Depreciation And Amortization | 300000.0000 | USD | 1 | us-gaap/2025 | Fair Value By Asset Class= Property Plant And Equipment; | ||
| 0001213900-25-042011 | 20250331 | Increase Decrease In Other Noncurrent Assets | -288000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Net Cash Provided By Used In Investing Activities | 4000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Other Assets Noncurrent | 820000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Other Assets Noncurrent | 532000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Other Noncash Expense | 116000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Restricted Cash Noncurrent | 417000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Shares Outstanding | 15022122.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042011 | 20231231 | Stockholders Equity | -169600000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042011 | 20241231 | Stockholders Equity | -240869000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001213900-25-042011 | 20240331 | Stock Issued During Period Value Stock Options Exercised | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | |||
| 0001213900-25-042011 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 15022122.0000 | shares | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Stockholders Equity | 113230000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Accounts Payable And Other Accrued Liabilities Current | 300000.0000 | USD | 0 | us-gaap/2025 | Plan Name= Two Zero Two Four E S P P; | ||
| 0001213900-25-042011 | 20240331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | 1169000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Assets | 57597000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 118892000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -22838000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Earnings Per Share Basic | -1.0300 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Liabilities Current | 15237000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Nonoperating Income Expense | 1344000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Operating Lease Liability Current | 1835000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2025 | ||||
| 0001213900-25-042011 | 20241231 | Prepaid Expense And Other Assets Current | 4174000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Prepaid Expense And Other Assets Current | 4375000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Property Plant And Equipment Net | 1875000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Accounts Payable Current | 4027000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | |||
| 0001213900-25-042011 | 20241231 | Assets | 79899000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Assets Current | 53174000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Cash And Cash Equivalents At Carrying Value | 71637000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Common Stock Shares Authorized | 492000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Common Stock Shares Authorized | 2000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Non Voting Common Stock; | ||
| 0001213900-25-042011 | 20250331 | Common Stock Shares Authorized | 490000000.0000 | shares | 0 | us-gaap/2025 | Class Of Stock= Voting Common Stock; | ||
| 0001213900-25-042011 | 20250331 | Common Stock Shares Issued | 15022122.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Earnings Per Share Basic | -1.4100 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -1728000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -218000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Liabilities Current | 12334000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | |||
| 0001213900-25-042011 | 20250331 | Net Income Loss | -21241000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Operating Lease Liability Noncurrent | 724000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Operating Lease Right Of Use Asset | 976000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Other Liabilities Noncurrent | 2264000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Other Nonoperating Income Expense | -42000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Other Nonoperating Income Expense | -63000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20241231 | Preferred Stock Shares Issued | shares | 0 | us-gaap/2025 | ||||
| 0001213900-25-042011 | 20240331 | Proceeds From Stock Options Exercised | 154000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20250331 | Property Plant And Equipment Net | 1599000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001213900-25-042011 | 20240331 | Shares Outstanding | 15085553.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042011 | 20250331 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001213900-25-042011 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 154000.0000 | USD | 1 | us-gaap/2025 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Operating Lease Liability Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash and Cash Equivalent | Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Accounts Payable And Other Accrued Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable and Other Accrued Liabilities, Current | Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer. |
| Earnings Per Share Diluted | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation | Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Proceeds From Issuance Of Common Stock | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Property Plant And Equipment Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Increase Decrease In Operating Lease Liability | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Investment Income Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Additional Paid In Capital | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Increase Decrease In Accounts Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Stock Issued During Period Value Issuance Of Common Stock Through Underwritten Offering | 0001213900-25-042011 | 1 | 0 | monetary | D | C | Stock Issued During Period Value Issuance Of Common Stock Through Underwritten Offering | Represent the amount of issuance of common stock through underwritten offering. |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | us-gaap/2025 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. |
| Operating Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Research And Development Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Operating Lease Liability Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Operating Lease Right Of Use Asset | us-gaap/2025 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Other Liabilities Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Proceeds From Sale Of Property Plant And Equipment | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Sale of Property, Plant, and Equipment | The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. |
| Restricted Cash Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Restricted Cash, Noncurrent | Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Issuance Of Common Stock Through Underwritten Offering Net Of Discounts And Commissions And Issuance Cost | 0001213900-25-042011 | 1 | 0 | shares | D | Issuance Of Common Stock Through Underwritten Offering Net Of Discounts And Commissions And Issuance Cost | Represent the number of issuance of common stock through underwritten offering, net of discounts and commissions and issuance cost | |
| Stock Issued During Period Value Net Of Discounts And Commissions And Issuance Cost | 0001213900-25-042011 | 1 | 0 | monetary | D | C | Stock Issued During Period Value Net Of Discounts And Commissions And Issuance Cost | Represent the amount of net of discounts and commissions and issuance cost. |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Payments To Acquire Machinery And Equipment | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Machinery and Equipment | The cash outflow for acquisition of machinery and equipment. |
| Preferred Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Depreciation And Amortization | us-gaap/2025 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Other Assets Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | D | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2025 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Other Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Prepaid Expense And Other Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | Amount of increase (decrease) in accrued expenses, and obligations classified as other. |
| Preferred Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Other Noncash Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Other Noncash Expense | Amount of expense or loss included in net income that result in no cash flow, classified as other. |
| Preferred Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Proceeds From Stock Options Exercised | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Reclassification Of Common Stock Warrant Liability To Equity | 0001213900-25-042011 | 1 | 0 | monetary | D | C | Reclassification Of Common Stock Warrant Liability To Equity | Reclassification of common stock warrant liability to equity. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Increase Decrease In Other Noncurrent Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Noncurrent Assets | Amount of increase (decrease) in noncurrent assets classified as other. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001213900-25-042011 | 5 | 16 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance Ending | 0 |
| 0001213900-25-042011 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
| 0001213900-25-042011 | 2 | 4 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2025 | Prepaid expenses and other current assets | 0 |
| 0001213900-25-042011 | 2 | 5 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001213900-25-042011 | 2 | 6 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2025 | Property and equipment, net | 0 |
| 0001213900-25-042011 | 2 | 7 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2025 | Operating lease right-of-use assets | 0 |
| 0001213900-25-042011 | 2 | 8 | BS | 0 | H | Restricted Cash Noncurrent | us-gaap/2025 | Restricted cash | 0 |
| 0001213900-25-042011 | 2 | 9 | BS | 0 | H | Other Assets Noncurrent | us-gaap/2025 | Other non-current assets | 0 |
| 0001213900-25-042011 | 2 | 10 | BS | 0 | H | Assets | us-gaap/2025 | Total assets | 0 |
| 0001213900-25-042011 | 2 | 13 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
| 0001213900-25-042011 | 2 | 14 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2025 | Current portion of operating lease liabilities | 0 |
| 0001213900-25-042011 | 2 | 15 | BS | 0 | H | Accounts Payable And Other Accrued Liabilities Current | us-gaap/2025 | Accrued expenses and other current liabilities | 0 |
| 0001213900-25-042011 | 2 | 16 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
| 0001213900-25-042011 | 2 | 17 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2025 | Non-current portion of operating lease liabilities | 0 |
| 0001213900-25-042011 | 2 | 18 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2025 | Other non-current liabilities | 0 |
| 0001213900-25-042011 | 2 | 19 | BS | 0 | H | Liabilities | us-gaap/2025 | Total liabilities | 0 |
| 0001213900-25-042011 | 2 | 20 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | Commitments and contingencies (Note 7) | 0 |
| 0001213900-25-042011 | 2 | 21 | BS | 0 | H | Preferred Stock Value | us-gaap/2025 | Preferred stock: $0.0001 par value 10,000,000 shares authorized at March 31, 2025 and December 31, 2024; none issued and outstanding at March 31, 2025 and December 31, 2024 | 0 |
| 0001213900-25-042011 | 2 | 22 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock: $0.0001 par value 492,000,000 shares authorized at March 31, 2025 and December 31, 2024; 15,022,122 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001213900-25-042011 | 2 | 23 | BS | 0 | H | Additional Paid In Capital | us-gaap/2025 | Additional paid-in capital | 0 |
| 0001213900-25-042011 | 2 | 24 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
| 0001213900-25-042011 | 2 | 25 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total stockholders equity | 0 |
| 0001213900-25-042011 | 2 | 26 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total liabilities and stockholders equity | 0 |
| 0001213900-25-042011 | 3 | 1 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2025 | Preferred stock, par value (in Dollars per share) | 0 |
| 0001213900-25-042011 | 3 | 2 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2025 | Preferred stock, shares authorized | 0 |
| 0001213900-25-042011 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2025 | Preferred stock, shares issued | 0 |
| 0001213900-25-042011 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2025 | Preferred stock, shares outstanding | 0 |
| 0001213900-25-042011 | 3 | 5 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common stock, par value (in Dollars per share) | 0 |
| 0001213900-25-042011 | 3 | 6 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common stock, shares authorized | 0 |
| 0001213900-25-042011 | 3 | 7 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common stock, shares issued | 0 |
| 0001213900-25-042011 | 3 | 8 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common stock, shares outstanding | 0 |
| 0001213900-25-042011 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2025 | Research and development | 0 |
| 0001213900-25-042011 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General and administrative | 0 |
| 0001213900-25-042011 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2025 | Total operating expenses | 0 |
| 0001213900-25-042011 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | Loss from operations | 0 |
| 0001213900-25-042011 | 4 | 6 | IS | 0 | H | Investment Income Interest | us-gaap/2025 | Interest income | 0 |
| 0001213900-25-042011 | 4 | 7 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2025 | Other expense, net | 0 |
| 0001213900-25-042011 | 4 | 8 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2025 | Total other income, net | 0 |
| 0001213900-25-042011 | 4 | 9 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net loss and comprehensive loss | 0 |
| 0001213900-25-042011 | 4 | 10 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Net loss per share attributable to common stockholders, basic (in Dollars per share) | 0 |
| 0001213900-25-042011 | 4 | 11 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2025 | Net loss per share attributable to common stockholders, diluted (in Dollars per share) (in Dollars per share) | 0 |
| 0001213900-25-042011 | 4 | 12 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in Shares) | 0 |
| 0001213900-25-042011 | 4 | 13 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2025 | Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in Shares) (in Shares) | 0 |
| 0001213900-25-042011 | 5 | 8 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance Beginning | 0 |
| 0001213900-25-042011 | 5 | 9 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance Beginning (in Shares) | 0 |
| 0001213900-25-042011 | 5 | 10 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2025 | Issuance of common stock upon exercise of stock options | 0 |
| 0001213900-25-042011 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2025 | Issuance of common stock upon exercise of stock options (in Shares) | 0 |
| 0001213900-25-042011 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Value Issuance Of Common Stock Through Underwritten Offering | 0001213900-25-042011 | Issuance of common stock through underwritten offering, net of discounts and commissions and issuance costs of $3.3 million | 0 |
| 0001213900-25-042011 | 5 | 13 | EQ | 0 | H | Issuance Of Common Stock Through Underwritten Offering Net Of Discounts And Commissions And Issuance Cost | 0001213900-25-042011 | Issuance of common stock through underwritten offering, net of discounts and commissions and issuance costs of $3.3 million (in Shares) | 0 |
| 0001213900-25-042011 | 5 | 14 | EQ | 0 | H | Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | us-gaap/2025 | Stock-based compensation expense | 0 |
| 0001213900-25-042011 | 5 | 15 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001213900-25-042011 | 5 | 17 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance Ending (in Shares) | 0 |
| 0001213900-25-042011 | 6 | 1 | EQ | 1 | H | Stock Issued During Period Value Net Of Discounts And Commissions And Issuance Cost | 0001213900-25-042011 | Issuance of common stock through underwritten offering, net of discounts and commissions and issuance costs | 0 |
| 0001213900-25-042011 | 7 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001213900-25-042011 | 7 | 4 | CF | 0 | H | Depreciation And Amortization | us-gaap/2025 | Depreciation and amortization expense | 0 |
| 0001213900-25-042011 | 7 | 5 | CF | 0 | H | Other Noncash Expense | us-gaap/2025 | Non-cash lease expense | 0 |
| 0001213900-25-042011 | 7 | 6 | CF | 0 | H | Share Based Compensation | us-gaap/2025 | Stock-based compensation expense | 0 |
| 0001213900-25-042011 | 7 | 8 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid expenses and other current assets | 1 |
| 0001213900-25-042011 | 7 | 9 | CF | 0 | H | Increase Decrease In Other Noncurrent Assets | us-gaap/2025 | Other non-current assets | 1 |
| 0001213900-25-042011 | 7 | 10 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2025 | Accounts payable | 0 |
| 0001213900-25-042011 | 7 | 11 | CF | 0 | H | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2025 | Accrued expenses and other current liabilities | 0 |
| 0001213900-25-042011 | 7 | 12 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2025 | Operating lease liability | 0 |
| 0001213900-25-042011 | 7 | 13 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash used in operating activities | 0 |
| 0001213900-25-042011 | 7 | 15 | CF | 0 | H | Payments To Acquire Machinery And Equipment | us-gaap/2025 | Purchases of property and equipment | 1 |
| 0001213900-25-042011 | 7 | 16 | CF | 0 | H | Proceeds From Sale Of Property Plant And Equipment | us-gaap/2025 | Proceeds from sales of property and equipment | 0 |
| 0001213900-25-042011 | 7 | 17 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Net cash provided by (used in) investing activities | 0 |
| 0001213900-25-042011 | 7 | 19 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2025 | Proceeds from issuance of common stock through ATM and underwritten offerings, net | 0 |
| 0001213900-25-042011 | 7 | 20 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2025 | Proceeds from exercise of common stock options | 0 |
| 0001213900-25-042011 | 7 | 21 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash provided by financing activities | 0 |
| 0001213900-25-042011 | 7 | 22 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2025 | Net increase (decrease) in cash, cash equivalents and restricted cash | 0 |
| 0001213900-25-042011 | 7 | 23 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash, cash equivalents and restricted cash at beginning of the period | 0 |
| 0001213900-25-042011 | 7 | 24 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Cash, cash equivalents and restricted cash at end of the period | 0 |
| 0001213900-25-042011 | 7 | 26 | CF | 0 | H | Reclassification Of Common Stock Warrant Liability To Equity | 0001213900-25-042011 | Right-of-use asset obtained in exchange for lease liabilities | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |